Stocklytics Platform
Asset logo for symbol HIMS
Hims & Hers Health
High Growth
Asset logo for symbol HIMS



Performance History

Chart placeholder
Key Stats
Prev. Close$20.37
Next Earnings Date-
Dividend Yield %-
PE Ratio-
Day Range19.04
52 Week Range5.65

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Perf. (24h)
Market Cap$569.64B
Perf. (24h)
Market Cap$397.54B
Perf. (24h)
Market Cap$372.12B
Perf. (24h)
Market Cap$280.83B

About Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Consumer Defensive
Household & Personal Products
Mr. Andrew Dudum
San Francisco
add Hims & Hers Health to watchlist

Keep an eye on Hims & Hers Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

Is Hims & Hers Health (HIMS) a growth stock?

Hims & Hers Health (HIMS) has shown an average price growth of 0.41% over the past three years. It has received a score of 85 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Hims & Hers Health as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

What is Hims & Hers Health's (HIMS) price per share?

The current price per share for Hims & Hers Health (HIMS) is $19.42. The stock has seen a price change of -$0.95 recently, indicating a -4.66% change. This reflects the stock's recent market performance and investor sentiment.

What is the 52-week high and low for Hims & Hers Health (HIMS)?

For Hims & Hers Health (HIMS), the 52-week high is $25.74, which is 32.54% from the current price. The 52-week low is $5.65, the current price is 243.72% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

What is Hims & Hers Health (HIMS) stock price performance year to date (YTD)?

As of the latest data, Hims & Hers Health (HIMS) has a year-to-date price change of 101.45%. Over the past month, the stock has experienced a price change of -13.26%. Over the last three months, the change has been 63.19%. Over the past six months, the figure is 133.41%.

Is Hims & Hers Health (HIMS) a profitable company?

Hims & Hers Health (HIMS) has a net income of -$23.55M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 80.9% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 3.59% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $872M, with a revenue growth rate of 65.49%, providing insight into the company's sales performance and growth. The gross profit is $705.43M. Operating income is noted at -$33.46M. Furthermore, the EBITDA is $5.2M.

What is the market capitalization of Hims & Hers Health (HIMS)?

Hims & Hers Health (HIMS) has a market capitalization of $4.72B. The average daily trading volume is 7.65M, indicating the stock's liquidity and investor engagement.



Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level